Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Amentoflavone** is a naturally occurring biflavonoid formed by the oxidative coupling of two apigenin molecules at positions C-3 (hydroxyphenyl ring) and C-8 (chromene ring)[2][5][8][7]. It is found in a variety of plants such as *Selaginella tamariscina*, *Ginkgo biloba*, *Hypericum perforatum* (St. John’s Wort), and others[4][7]. Amentoflavone exhibits **multifunctional biological activity**: it acts as an anti-inflammatory, antioxidant, antiviral, antidiabetic, neuroprotective, anticancer, anti-microbial, anti-senescence, and anti-fungal agent[1][7][13]. Mechanistically, it inhibits signaling pathways like ERK, NF-κB, PI3K/Akt, GLI-1/IL-6/STAT3, and enzymes such as cathepsin B, CYP3A4, CYP2C9, group II phospholipase A2, and cyclooxygenase[1][4][10][14][16]. It also antagonizes the κ-opioid receptor and is a negative allosteric modulator at the allosteric benzodiazepine site of the GABA_A receptor[4][16]. Recent research highlights its inhibition of SARS-CoV-2 via strong binding to 3CLpro (main protease), spike protein RBD, and RNA-dependent RNA polymerase, as well as its suppression of fatty acid synthase[1][6][13]. Pharmacokinetic studies suggest low oral bioavailability due to rapid metabolism[7]. While clinical development is ongoing for antiviral indications (notably COVID-19), most evidence is preclinical and pharmacological[6]. No brand products or commercial formulations with amentoflavone as a single agent are currently approved.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amentoflavone.